跳至主要内容
附件 II 条目 1605 CMR已修订 30 七月 2020

N,N'-Methylenedimorpholine; N,N'-methylenebismorpholine; [formaldehyde released from N,N'-Methylenebismorpholine]; [MBM] if the maximum theoretical concentration of releasable formaldehyde, irrespective of the source, in the mixture as placed on the market is = 0,1 % w/w

N,N'-Methylenedimorpholine; N,N'-methylenebismorpholine; [formaldehyde released from N,N'-Methylenebismorpholine]; [MBM] if the maximum theoretical concentration of releasable formaldehyde, irrespective of the source, in the mixture as placed on the market is = 0,1 % w/w 在附件 II 中被列为在欧盟市场上市的化妆品的禁用物质。

禁用物质— 附件 II, 欧盟法规 1223/2009
条目: 1605
CMR

记录详情

化学名称

N,N'-Methylenedimorpholine; N,N'-methylenebismorpholine; [formaldehyde released from N,N'-Methylenebismorpholine]; [MBM] if the maximum theoretical concentration of releasable formaldehyde, irrespective of the source, in the mixture as placed on the market is = 0,1 % w/w

化学名称 / IUPAC 名称

N,N'-Methylenedimorpholine; N,N'-methylenebismorpholine; [formaldehyde released from N,N'-Methylenebismorpholine]; [MBM] if the maximum theoretical concentration of releasable formaldehyde, irrespective of the source, in the mixture as placed on the market is = 0,1 % w/w

监管信息

法规

(EU) 2019/831

查看该法案设定的所有条目

CMR

类别CarcinogenicMutagenicReprotoxic
Cat. 1B✓——
Cat. 2—✓—

关键数据

附件
条目编号
1605

化学身份与性质

CAS 5625-90-1 的 PubChem 二维化学结构
CAS 5625-90-1PubChem CID 21839

Dimorpholinomethane

IUPAC 名称
4-(morpholin-4-ylmethyl)morpholine
分子式
C9H18N2O2
分子量
186.25 g/mol
精确质量
186.136827821 Da
XLogP3
-0.3
拓扑极性表面积
24.9 Ų
氢键供体
0
氢键受体
4
共价单元
1
已定义的立体中心
0

又称

4,4-MethylenedimorpholineMORPHOLINE, 4,4'-METHYLENEDI-7O79DZW79Z4,4-methylene-bismorpholineRefChem:506837N,N'-Dimorpholinomethane4,4'-MethylenedimorpholineMorpholine, 4,4'-methylenebis-
另有 16 个已报告名称
N,N'-Methylenebismorpholine4-[(morpholin-4-yl)methyl]morpholinebis(4-morpholinyl)methane4,4'-Methylenebismorpholine4,4'-METHYLENEBIS(MORPHOLINE)DimorpholinomethoneBismorpholino methaneBis(morpholino-)methan [German]Bis(morpholino-)methanEINECS 227-062-3BRN 0111886UNII-7O79DZW79Z4-(morpholinomethyl)morpholineAI3-62944bismorpholinomethaneContram ST-1
外部数据库标识符

于 2026-09-02 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。

该记录的直接匹配结果有限,因此同时显示附件 II 中的相邻条目。

附件 II 1608
同一附件中的相邻记录

Methylhydrazine

CAS: 60-34-4
EC: 200-471-4

附件 II 对 N,N'-Methylenedimorpholine; N,N'-methylenebismorpholine; [formaldehyde released from N,N'-Methylenebismorpholine]; [MBM] if the maximum theoretical concentration of releasable formaldehyde, irrespective of the source, in the mixture as placed on the market is = 0,1 % w/w 意味着什么

N,N'-Methylenedimorpholine; N,N'-methylenebismorpholine; [formaldehyde released from N,N'-Methylenebismorpholine]; [MBM] if the maximum theoretical concentration of releasable formaldehyde, irrespective of the source, in the mixture as placed on the market is = 0,1 % w/w 被列为欧盟化妆品法规 1223/2009 附件 II 中的禁用物质,不得有意添加。第 17 条另行规定了在良好生产规范下技术上不可避免、且符合第 3 条安全要求的非有意微量存在的情形。

配方师必须筛查其成分和原料,确保均不含该物质。供应商应在被要求时提供证明不含该物质的文件。

本页还显示 12 条相关附件记录,其标识符、附件逻辑或命名模式存在重叠。

合规核查清单

  • 核实该物质不存在于所有原料和成品配方中。
  • 向原料供应商索取不含该物质的确认函或 CoA。
  • 将筛查结果记录在产品信息档案 (PIF) 中。
  • 该物质具有 CMR 分类。使用前请查看上方的 CMR 表,并核实现行附件 II/III 状态。

常见问题

是。N,N'-Methylenedimorpholine; N,N'-methylenebismorpholine; [formaldehyde released from N,N'-Methylenebismorpholine]; [MBM] if the maximum theoretical concentration of releasable formaldehyde, irrespective of the source, in the mixture as placed on the market is = 0,1 % w/w 列于欧盟化妆品法规 1223/2009 的附件 II,禁止作为化妆品成分有意添加。第 17 条对在良好生产规范下技术上不可避免的非有意微量存在规定了狭窄的例外,前提是产品仍符合第 3 条的安全要求。

CAS 5625-90-1 是化学文摘社 (Chemical Abstracts Service) 分配给 N,N'-Methylenedimorpholine; N,N'-methylenebismorpholine; [formaldehyde released from N,N'-Methylenebismorpholine]; [MBM] if the maximum theoretical concentration of releasable formaldehyde, irrespective of the source, in the mixture as placed on the market is = 0,1 % w/w 的唯一数字标识符。在化妆品合规工作中,CAS 编号用于在监管数据库、原料规格书和安全评估报告之间交叉引用该物质。如果同一物质在不同条件下或不同附件中出现,多个欧盟附件条目可能共用同一 CAS 编号。

N,N'-Methylenedimorpholine; N,N'-methylenebismorpholine; [formaldehyde released from N,N'-Methylenebismorpholine]; [MBM] if the maximum theoretical concentration of releasable formaldehyde, irrespective of the source, in the mixture as placed on the market is = 0,1 % w/w 在欧盟 CLP 法规下具有 CMR(致癌、致突变或生殖毒性)分类。根据欧盟化妆品法规 1223/2009 第 15 条,1A 类或 1B 类 CMR 物质禁止用于化妆品,除非被特别允许。2 类 CMR 物质只有经 SCCS 评估为安全才可使用。使用前请务必核实现行附件状态及任何适用的豁免。

使用本站的 INCI 检查器工具粘贴您的完整成分表 (INCI),并对照所有附件 II–VI 条目进行扫描。该工具会突出显示与限用、禁用或致敏原标记记录相匹配的成分。这有助于对成品配方或原料声明进行快速合规筛查。

附件 II 记录 N,N'-Methylenedimorpholine; N,N'-methylenebismorpholine; [formaldehyde released from N,N'-Methylenebismorpholine]; [MBM] if the maximum theoretical concentration of releasable formaldehyde, irrespective of the source, in the mixture as placed on the market is = 0,1 % w/w 的来源说明

本页概述欧盟委员会公开化妆品资料中 N,N'-Methylenedimorpholine; N,N'-methylenebismorpholine; [formaldehyde released from N,N'-Methylenebismorpholine]; [MBM] if the maximum theoretical concentration of releasable formaldehyde, irrespective of the source, in the mixture as placed on the market is = 0,1 % w/w 的一条附件 II 记录,并在可用时补充关联的清单或标识符匹配。

请使用本记录页面查看 N,N'-Methylenedimorpholine; N,N'-methylenebismorpholine; [formaldehyde released from N,N'-Methylenebismorpholine]; [MBM] if the maximum theoretical concentration of releasable formaldehyde, irrespective of the source, in the mixture as placed on the market is = 0,1 % w/w 的附件 II 条件,但任何最终监管决定都应对照现行官方附件措辞和来源文件确认。

工具与后续步骤

检查您的配方

粘贴完整的 INCI 成分表,一次性检出 N,N'-Methylenedimorpholine; N,N'-methylenebismorpholine; [formaldehyde released from N,N'-Methylenebismorpholine]; [MBM] if the maximum theoretical concentration of releasable formaldehyde, irrespective of the source, in the mixture as placed on the market is = 0,1 % w/w 及其他被标记的欧盟附件记录。

INCI 检查器

条目对比

将 N,N'-Methylenedimorpholine; N,N'-methylenebismorpholine; [formaldehyde released from N,N'-Methylenebismorpholine]; [MBM] if the maximum theoretical concentration of releasable formaldehyde, irrespective of the source, in the mixture as placed on the market is = 0,1 % w/w 与另一条附件记录并排对比,查看限制、浓度和附件归属的差异。

对比

浏览附件

查看附件 II 中的所有记录,并对比该附件中各物质的监管条件。

打开附件 II